Identification of individuals at risk of hepatocellular carcinoma: screening for clinically significant liver fibrosis in patients with T2DM-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of individuals at risk of hepatocellular carcinoma: screening for clinically significant liver fibrosis in patients with T2DM

Published:2023-08-17 Issue:5 Volume:18 Page:355-359
ISSN:1744-6651
Container-title:Expert Review of Endocrinology & Metabolism
language:en
Short-container-title:Expert Review of Endocrinology & Metabolism

Author:

Reinson Tina¹²^ORCID,Buchanan Ryan M²³,Byrne Christopher D¹²

Affiliation:

1. Nutrition and Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK

2. National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK

3. Primary Care and Population Science, Faculty of Medicine, University of Southampton, Southampton, UK

Funder

the Southampton NIHR Biomedical Research Centre

Publisher

Informa UK Limited

Subject

Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/17446651.2023.2248242

Reference47 articles.

1. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records

2. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

3. Global burden of primary liver cancer in 2020 and predictions to 2040

4. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

5. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells;Current Research in Translational Medicine;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3